Literature DB >> 27473783

Spontaneous resolution of left bundle branch block and biventricular stimulation lead to reverse remodeling in dyssynchronopathy.

Mariëlle Kloosterman1, Michiel Rienstra1, Isabelle C Van Gelder1, Alexander H Maass2.   

Abstract

Left bundle branch block (LBBB) is considered a marker of underlying structural cardiac disease. To determine whether LBBB is cause or consequence of deterioration of left ventricular (LV) function is difficult as both are often diagnosed concomitantly. We discuss a patient where reversal of LBBB and subsequent normalization of LV function was observed after 2 different therapies, first after start of heart failure medication, and years later after implantation of a cardiac resynchronization device. This indicates that LBBB per se may result in the development of non-ischemic cardiomyopathy and that LBBB resolution can lead to reverse remodeling in dyssynchronopathy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Dyssynchronopathy; Left bundle branch block; Non-ischemic cardiomyopathy; Reverse remodeling

Mesh:

Year:  2016        PMID: 27473783     DOI: 10.1016/j.jelectrocard.2016.07.008

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  Transient left bundle branch block and intraventricular dyssynchrony as a cause of reversible left ventricular dysfunction: The "in vivo" documentation of spontaneous electrical remodeling.

Authors:  Eleonora Moccia; Giuseppe D Sanna; Guido Parodi
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-05-29       Impact factor: 1.468

2.  Heart rate reduction after ivabradine might be associated with reverse electrical remodeling in patients with cardiomyopathy and left bundle branch block.

Authors:  Andrea Kučerová; Petr Doškář; Libor Dujka; Veronika Lekešová; Petr Volf; Katarina Koščová; Petr Neužil; Filip Málek
Journal:  J Int Med Res       Date:  2018-09-18       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.